Oral anticoagulant

DRUG11 trials

Conditions

AnticoagulantsAnticoagulants and Bleeding DisordersAtherothrombosisAtrial FibrillationCardioversionCerebral Venous ThrombosisCerebrovascular StrokeIschem Heart Disease

Phase 3

Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation

CompletedNCT01924065

Suleyman Demirel UniversityAtrial Fibrillation, Cardioversion, Cerebrovascular Stroke

Start: 2013-08-31End: 2024-10-29Updated: 2024-11-15

Phase 4

Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis

TerminatedNCT03062319

National Hospital Organization Osaka National HospitalAtherothrombosis, Atrial Fibrillation, Ischemic Stroke

Start: 2017-04-06End: 2023-07-18Updated: 2024-12-27

A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF

CompletedNCT04907825

Cedars-Sinai Medical CenterAtrial Fibrillation, Stroke

Start: 2023-03-13End: 2026-01-31Updated: 2026-03-18

Unknown Phase

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

CompletedNCT03292666

University of California, San FranciscoAnticoagulants and Bleeding Disorders, Venous Thromboembolism

Start: 2010-01-01End: 2022-06-21Updated: 2022-11-02

CHAOS Registry Study

NCT03558295

A.O.U. Città della Salute e della ScienzaAtrial Fibrillation, Ischem Heart Disease, Oral Anticoagulants +1

Start: 2018-05-01End: 2018-12-31Target: 1000Updated: 2018-06-15

Anticoagulation After RFCA

NCT03573037

Yong Seog OhAtrial Fibrillation

Start: 2014-07-31End: 2020-08-31Target: 246Updated: 2018-07-27

Obesity Paradox in Non Valvular Atrial Fibrillation Regarding Outcomes: Fact or Fiction

NCT03904329

Assiut UniversityObesity Paradox

Start: 2020-10-01End: 2023-10-01Target: 1Updated: 2022-08-04

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

CompletedNCT04099238

BayerAtrial Fibrillation

Start: 2019-10-01End: 2020-07-16Updated: 2021-04-26

Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County

CompletedNCT04233515

Region Örebro CountyAtrial Fibrillation, Stroke, Ischemic

Start: 2019-09-02End: 2021-01-29Updated: 2023-04-25

Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis

RecruitingNCT04660747

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Cerebral Venous Thrombosis

Start: 2021-01-27End: 2028-01-31Target: 1300Updated: 2024-08-19

Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation

NCT05645913

Ajou University School of MedicineAnticoagulants, Atrial Fibrillation, Obesity +1

Start: 2022-01-01End: 2024-12-31Updated: 2023-07-27

Related Papers

Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis: A Randomized Clinical Trial.

2025-12-012 citations

Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study.

2025-03-012 citations

Optimal antithrombotic therapy in ischemic stroke patients with non-valvular atrial fibrillation and atherothrombosis: study protocol for a randomized controlled trial

Frontiers in Neurology2024-10-231 citations

Direct oral anticoagulants for the treatment of cerebral venous thrombosis – a protocol of an international phase IV study

Frontiers in Neurology2023-09-1413 citations